Patrice La Vigne – Nordic Cochrane Center Files Complaint About Scientific Misconduct, Secrecy in HPV Vaccine Probe in Europe

Nordic Cochrane Center, a Danish research and information center is challenging the European Medicines Agency’s (EMA) 2015 report on human papillomavirus (HPV) vaccines and the EMA’s position that HPV vaccine benefits outweigh the risks. After numerous reports of HPV vaccine-related brain and immune system injuries and deaths, the Danish Health and Medicines Authority asked the EMA to conduct the probe into HPV vaccine safety, but prominent physicians in the country are not convinced about the EMA’s conclusions downplaying the vaccine’s risks.

In 2015, the EMA conducted an investigation of the three HPV vaccines, including Gardasil and Cervarix, available in the United States and countries in the European Union (EU) in response to reports of several HPV-related adverse events, including complex regional pain syndrome (CRPS) and postural orthostatic tachycardia syndrome (POTS), two inflammatory autoimmune conditions.

Read more